Stock Taper
AEON
AEON BIOPHARMA, INC.
AMEX
$0.31
▲ UP 6.91% (0.02)

KEY STATISTICS

Market Cap$13.87 M
52w High$1.45
52w Low$0.18
Dividend Yield
Frequency
P/E-0.06
Volume1.10M
Shares Out.44.16M

COMPANY

LEADERSHIP

Robert Bancroft
CHIEF EXECUTIVE
Robert Bancroft

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 24, 2023
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
8

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.
NOV
13
FRI

SPLIT RECORD

DATETYPERATIO
2025-02-26Reverse1:72

PRICE

$0.31 ▲ UP 6.91% (+$0.02)
OVERLAYS
$0.28$0.29$0.30$0.319:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.31

About AEON Biopharma, Inc.

http://www.aeonbiopharma.com ↗

AEON Biopharma, Inc., founded in 2012 and based in Newport Beach, CA, develops botulinum toxins like ABP-450 for treating migraines, dystonia, and gastroparesis.

INDUSTRY

Biotechnology

A PRODUCT AEON BIOPHARMA, INC. IS KNOWN FOR

ABP-450 (prabotulinumtoxinA)
ABP-450 (prabotulinumtoxinA)

ABP-450 is a botulinum toxin complex in clinical development as a potential biosimilar to BOTOX®, targeting various medical conditions with an initial focus on the neurosciences market.

COMPETITORS

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

10 PERCENT OWNER
LYNCH TIMOTHY P
· —
2026-08-19
10 PERCENT OWNER
LYNCH TIMOTHY P
· 1.0M shares
2026-08-19
10 PERCENT OWNER
LYNCH TIMOTHY P
Purchase · 1.1M shares
2026-08-19
10 PERCENT OWNER
LYNCH TIMOTHY P
· 3.0M shares
2026-07-15

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CING$5.33COMPARE
CLNN$4.23COMPARE
MRKR$1.37COMPARE
CLRB$2.53COMPARE
BOLT$3.81COMPARE
MBIO$0.54COMPARE
OSRH$0.12COMPARE